GSK quits Kenya 4 months after Nigeria exit

GSK gets SEC’s approval for Scheme of Arrangement to delist from NGX

GlaxoSmithKline (GSK), a British pharmaceutical multinational, has quit Kenya four months after its market-shaking exit from Africa’s largest economy, Nigeria. In what appears to be a global restructuring of its business model, the company which produces prescription drugs and vaccines is set t

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```